US Stock MarketDetailed Quotes

Tenaya Therapeutics (TNYA)

Watchlist
  • 0.9595
  • -0.0405-4.05%
Close May 13 16:00 ET
  • 0.9708
  • +0.0113+1.18%
Pre 04:44 ET
208.21MMarket Cap-2.18P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tenaya Therapeutics (TNYA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
225K
0
0
0
0
0
0
0
0
0
Operating revenue
--225K
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.32%20.29M
-19.51%93.33M
-15.73%20.78M
-21.62%20.94M
-21.87%24.08M
-18.43%27.54M
-11.62%115.95M
-21.61%24.65M
-13.61%26.71M
-12.20%30.82M
Selling and administrative expenses
-15.71%5.45M
-15.35%24.72M
0.22%5.98M
-12.39%5.57M
-17.89%6.71M
-25.78%6.46M
-11.91%29.21M
-30.50%5.96M
-18.75%6.36M
-5.25%8.17M
-General and administrative expense
-15.71%5.45M
-15.35%24.72M
0.22%5.98M
-12.39%5.57M
-17.89%6.71M
-25.78%6.46M
-11.91%29.21M
-30.50%5.96M
-18.75%6.36M
-5.25%8.17M
Research and development costs
-29.57%14.84M
-20.91%68.61M
-20.82%14.8M
-24.51%15.36M
-23.31%17.37M
-15.88%21.08M
-11.52%86.74M
-18.27%18.69M
-11.87%20.35M
-14.46%22.65M
Operating profit
27.14%-20.07M
19.51%-93.33M
15.73%-20.78M
21.62%-20.94M
21.87%-24.08M
18.43%-27.54M
11.62%-115.95M
21.61%-24.65M
13.61%-26.71M
12.20%-30.82M
Net non-operating interest income expense
24.88%793K
-43.38%2.68M
-29.19%575K
-39.07%658K
-41.49%815K
-56.27%635K
-32.87%4.74M
-44.76%812K
-39.19%1.08M
-24.17%1.39M
Non-operating interest income
24.88%793K
-43.38%2.68M
-29.19%575K
-39.07%658K
-41.49%815K
-56.27%635K
-32.87%4.74M
-44.76%812K
-39.19%1.08M
-24.17%1.39M
Other net income (expense)
-36.59%52K
525.00%25K
200.00%3K
-1,500.00%-16K
-52.44%39K
54.72%82K
-90.24%4K
-400.00%-3K
50.00%-1K
Other non- operating income (expenses)
----
-36.59%52K
525.00%25K
200.00%3K
-1,500.00%-16K
-52.44%39K
54.72%82K
-90.24%4K
-400.00%-3K
50.00%-1K
Income before tax
28.26%-19.27M
18.48%-90.6M
15.36%-20.18M
20.91%-20.28M
20.89%-23.28M
16.64%-26.86M
10.44%-111.13M
20.37%-23.84M
12.04%-25.63M
11.54%-29.43M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
28.26%-19.27M
18.48%-90.6M
15.36%-20.18M
20.91%-20.28M
20.89%-23.28M
16.64%-26.86M
10.44%-111.13M
20.37%-23.84M
12.04%-25.63M
11.54%-29.43M
Net income continuous Operations
28.26%-19.27M
18.48%-90.6M
15.36%-20.18M
20.91%-20.28M
20.89%-23.28M
16.64%-26.86M
10.44%-111.13M
20.37%-23.84M
12.04%-25.63M
11.54%-29.43M
Minority interest income
Net income attributable to the parent company
28.26%-19.27M
18.48%-90.6M
15.36%-20.18M
20.91%-20.28M
20.89%-23.28M
16.64%-26.86M
10.44%-111.13M
20.37%-23.84M
12.04%-25.63M
11.54%-29.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.26%-19.27M
18.48%-90.6M
15.36%-20.18M
20.91%-20.28M
20.89%-23.28M
16.64%-26.86M
10.44%-111.13M
20.37%-23.84M
12.04%-25.63M
11.54%-29.43M
Basic earnings per share
62.50%-0.09
54.96%-0.59
57.14%-0.12
60.00%-0.12
58.82%-0.14
40.00%-0.24
22.02%-1.31
30.00%-0.28
23.08%-0.3
24.44%-0.34
Diluted earnings per share
62.50%-0.09
54.96%-0.59
57.14%-0.12
60.00%-0.12
58.82%-0.14
40.00%-0.24
22.02%-1.31
30.00%-0.28
23.08%-0.3
24.44%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 225K000000000
Operating revenue --225K--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.32%20.29M-19.51%93.33M-15.73%20.78M-21.62%20.94M-21.87%24.08M-18.43%27.54M-11.62%115.95M-21.61%24.65M-13.61%26.71M-12.20%30.82M
Selling and administrative expenses -15.71%5.45M-15.35%24.72M0.22%5.98M-12.39%5.57M-17.89%6.71M-25.78%6.46M-11.91%29.21M-30.50%5.96M-18.75%6.36M-5.25%8.17M
-General and administrative expense -15.71%5.45M-15.35%24.72M0.22%5.98M-12.39%5.57M-17.89%6.71M-25.78%6.46M-11.91%29.21M-30.50%5.96M-18.75%6.36M-5.25%8.17M
Research and development costs -29.57%14.84M-20.91%68.61M-20.82%14.8M-24.51%15.36M-23.31%17.37M-15.88%21.08M-11.52%86.74M-18.27%18.69M-11.87%20.35M-14.46%22.65M
Operating profit 27.14%-20.07M19.51%-93.33M15.73%-20.78M21.62%-20.94M21.87%-24.08M18.43%-27.54M11.62%-115.95M21.61%-24.65M13.61%-26.71M12.20%-30.82M
Net non-operating interest income expense 24.88%793K-43.38%2.68M-29.19%575K-39.07%658K-41.49%815K-56.27%635K-32.87%4.74M-44.76%812K-39.19%1.08M-24.17%1.39M
Non-operating interest income 24.88%793K-43.38%2.68M-29.19%575K-39.07%658K-41.49%815K-56.27%635K-32.87%4.74M-44.76%812K-39.19%1.08M-24.17%1.39M
Other net income (expense) -36.59%52K525.00%25K200.00%3K-1,500.00%-16K-52.44%39K54.72%82K-90.24%4K-400.00%-3K50.00%-1K
Other non- operating income (expenses) -----36.59%52K525.00%25K200.00%3K-1,500.00%-16K-52.44%39K54.72%82K-90.24%4K-400.00%-3K50.00%-1K
Income before tax 28.26%-19.27M18.48%-90.6M15.36%-20.18M20.91%-20.28M20.89%-23.28M16.64%-26.86M10.44%-111.13M20.37%-23.84M12.04%-25.63M11.54%-29.43M
Income tax 0000000000
Net income 28.26%-19.27M18.48%-90.6M15.36%-20.18M20.91%-20.28M20.89%-23.28M16.64%-26.86M10.44%-111.13M20.37%-23.84M12.04%-25.63M11.54%-29.43M
Net income continuous Operations 28.26%-19.27M18.48%-90.6M15.36%-20.18M20.91%-20.28M20.89%-23.28M16.64%-26.86M10.44%-111.13M20.37%-23.84M12.04%-25.63M11.54%-29.43M
Minority interest income
Net income attributable to the parent company 28.26%-19.27M18.48%-90.6M15.36%-20.18M20.91%-20.28M20.89%-23.28M16.64%-26.86M10.44%-111.13M20.37%-23.84M12.04%-25.63M11.54%-29.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.26%-19.27M18.48%-90.6M15.36%-20.18M20.91%-20.28M20.89%-23.28M16.64%-26.86M10.44%-111.13M20.37%-23.84M12.04%-25.63M11.54%-29.43M
Basic earnings per share 62.50%-0.0954.96%-0.5957.14%-0.1260.00%-0.1258.82%-0.1440.00%-0.2422.02%-1.3130.00%-0.2823.08%-0.324.44%-0.34
Diluted earnings per share 62.50%-0.0954.96%-0.5957.14%-0.1260.00%-0.1258.82%-0.1440.00%-0.2422.02%-1.3130.00%-0.2823.08%-0.324.44%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -